ArticleBMC cancer2015

Abiraterone acetate in patients with metastatic castration-resistant prostate cancer: long term outcome of the Temporary Authorization for Use programme in France.

Nadine Houédé et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.